Navigation Links
Drug Sorafenib Improves Kidney Cancer Outcomes
Date:10/9/2008

It helped older and younger patients, study says

THURSDAY, Oct. 9 (HealthDay News) -- People with kidney cancer, regardless of age, seem to benefit from and tolerate sorafenib drug therapy equally well, a new study says.

The finding, published online Oct. 7 in the Journal of the National Cancer Institute, counters the general perception that older patients derive less benefit from the therapy and are more likely to suffer side effects than younger patients.

The study, conducted by Tim Eisen of Addenbrooke's Hospital and the University of Cambridge in the United Kingdom and colleagues, found patients age 70 and older and those 69 and younger had similar responses to the drug in terms of self-reported health deterioration and improved quality of life over that time.

"Sorafenib treatment appeared to improve outcomes among patients with advanced renal cell carcinoma, regardless of age," the authors wrote. "Additionally, side effects were expected, mild, and medically manageable. There was no notable difference in the frequency or severity of sorafenib-related toxicity between younger and older patients."

The groups also had similar median progression-free survival times with young patients going almost 24 weeks and older ones just passing 26 weeks. The percentage of older patients who had a complete or partial response to the treatment or had the disease stabilize was 84.3 percent compared with 83.5 percent for the younger patients.

More information

The U.S. National Cancer Institute has more about kidney and renal cancer.



-- Kevin McKeever



SOURCE: Journal of the National Cancer Institute, news release, Oct. 7, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. Sorafenib Slows Growth of Some Leukemias
2. Analysis shows combining sorafenib with carboplatin/paclitaxel adds no benefit in lung cancer
3. Sorafenib Shows Promise for Heart-Lung Disease
4. Study Demonstrates Marteks Algal DHA Oil Improves Blood Triglyceride Lipid Levels
5. Exercise and yoga improves quality of life in women with early-stage breast cancer
6. Enhanced PrecyseCode 2X(TM) Further Accelerates Remote Coding and Improves Cash Flow for Hospitals
7. Weight-based dosing of ribavirin improves outcomes for patients with hepatitis C
8. Kerry Extends, Improves Small Business Innovation Program
9. Thalidomide Improves Outcomes for Older Myeloma Patients
10. Grape Consumption Improves Antioxidant Capacity in Humans
11. JCSM: CPAP therapy improves symptoms of depression in OSA patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2017)... , ... August 20, 2017 , ... ... HIPAA ComplyPAK™ Compliance Management System has assisted multiple clients in successfully ... Public Accountants, Service Organization Control Level 2 (AICPA SOC Level 2), and State ...
(Date:8/19/2017)... ... August 19, 2017 , ... ... will feature the Aurum Group in an upcoming episode, slated to air fourth ... Innovations will feature the Aurum Group; a company committed to supporting dentistry using ...
(Date:8/19/2017)... ... August 18, 2017 , ... ... Act of 2017, legislation that provides for greater public access to over-the-counter (OTC) ... loss to access OTC hearing aids without being seen by a certified and ...
(Date:8/19/2017)... ... August 19, 2017 , ... Praeclarus Press has launched a ... show the diversity of the breastfeeding mothers, using bright colors and contemporary ... These illustrations are also available on tote bags, notepads, smartphone cases, clocks, and ...
(Date:8/19/2017)... ... August 19, 2017 , ... Physician ... its Orlando location as an interventional pain management physician. He brings a wealth ... treatment of migraine headaches, and significant experience in spinal cord stimulation for chronic ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)... Aug. 7, 2017 Diplomat Pharmacy, Inc. (NYSE: ... Saban as president, effective Aug. 7, 2017. ... decided to pursue other interests and will serve as president ... Paul has served us in multiple leadership roles since he ... Jun. 2015 and has provided decisive, strategic leadership which continues ...
(Date:8/7/2017)... 2017  Endo International plc (NASDAQ: ENDP ... virtually all known U.S. mesh product liability claims and ... known remaining U.S. claims at reasonable values. Under the ... fourth quarter of 2017 and continuing through the fourth ... 2017 results, the Company intends to increase its mesh ...
(Date:8/4/2017)... CINCINNATI , Aug. 3, 2017  Agragen, ... science company active in the biopharmaceutical, nutraceutical, and ... its development of its lead drug candidates, AGR131.  ... a proinflammatory cytokine from the blood of patients ... psoriasis, and inflammatory bowel disease. ...
Breaking Medicine Technology: